Results 101 to 110 of about 2,992 (185)

Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome [PDF]

, 2015
Gamma-hydroxybutyrate (GHB) is a short chain fatty acid endogenously produced within the central nervous system (CNS) and acts as a precursor and metabolite of the inhibitory neurotransmitter γ-aminobutyric acid (GABA).
BUSARDO', FRANCESCO PAOLO, KYRIAKOU, CHRYSTALLA, MARINELLI, Enrico, NAPOLETANO, SIMONA, ZAAMI, Simona   +4 more
core  

Acamprosate in the treatment of alcoholism: a budget impact analysis for the National Health Service in Italy

Substance Abuse and Rehabilitation, 2012
Giorgio L Colombo,1,2 Sergio Di Matteo,2 Giacomo Bruno21Department of Drug Sciences, School of Pharmacy, University of Pavia, Pavia, Italy; 2S.A.V.E. – Studi Analisi Valutazioni Economiche, Milan, ItalyObjective: Alcohol dependence is a common ...
Colombo GL, Di Matteo S, Bruno G
doaj  

Living with Narcolepsy: Current Management Strategies, Future Prospects, and Overlooked Real-Life Concerns

Nature and Science of Sleep, 2020
Emily C Barker,1 Julie Flygare,2 Shalini Paruthi,3,4 Katherine M Sharkey5– 7 1Case Western Reserve University School of Medicine, Department of Pediatrics, Cleveland, OH, USA; 2Project Sleep, Los Angeles, CA, USA; 3Sleep Medicine and Research ...
Barker EC, Flygare J, Paruthi S, Sharkey KM   +3 more
doaj  

Do capillary dried blood spot concentrations of gamma-hydroxybutyric acid mirror those in venous blood? : a comparative study [PDF]

, 2015
Abanades, Andresen, Baselt, Berankova, Brennan, Elian, Elliott, Ingels, Ingels, Ingels, Ingels, Johansen, Petersen, Sadones, Schröck, Shima, Stove, Sørensen, Wood, Wood   +19 more
core   +1 more source

Sodium oxybate-a new horizon for symptomatic treatment of RBD? [PDF]

Sleep, 2023
Stefani A, Högl B, Videnovic A.
europepmc   +1 more source

Should sleepy patients see general neurologists? [PDF]

, 2014
Morrison, I.
core   +1 more source

Effects of sodium oxybate on hypocretin/orexin and locus coeruleus neurons. [PDF]

Sleep, 2023
Wu MF, Thannickal TC, Li S, McGregor R, Lai YY, Siegel JM.   +5 more
europepmc   +1 more source

Treatment cost of narcolepsy with cataplexy in Central Europe

Therapeutics and Clinical Risk Management, 2016
Petra Maresova,1 Michal Novotny,2,3 Blanka Klímová,4 Kamil Kuča3,51Department of Economics, Faculty of Informatics and Management, 2Department of Chemistry, Faculty of Science, University of Hradec Králové, 3Biomedical ...
Maresova P, Novotny M, Klímová B, Kuča K   +3 more
doaj  

Sodium oxybate in treatment-resistant rapid-eye-movement sleep behavior disorder. [PDF]

Sleep, 2023
During EH, Hernandez B, Miglis MG, Sum-Ping O, Hekmat A, Cahuas A, Ekelmans A, Yoshino F, Mignot E, Kushida CA.   +9 more
europepmc   +1 more source

A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome [PDF]

Charles F. P. George, Neil Feldman, Yanping Zheng, Teresa L. Steininger, Susanna M. Grzeschik, Chinglin Lai, Neil Inhaber, H Laborit, MD Vickers, MB Scharf, M Mamelak, L Scrima, GJ Lammers, US Xyrem® Multicenter Study Group, US Xyrem® Multicenter Study Group, US Xyrem® Multicenter Study Group, Xyrem® International Study Group, S Kleinschmidt, PE Mason, J Santamaria, A Bonakis, T Young, PE Peppard, AR Schwartz, A Schuld, N Dahmen, CFP George, MW Johns, American Academy of Sleep Medicine Task Force, A Rechtschaffen, R Zozula, MH Kryger, F Sériès, JE Black, R Ristanovic, G Aarab, LR Bittencourt, RM Wittig, D Pardi, R Godbout   +39 more
core   +1 more source